BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8167039)

  • 41. Management of N0 neck in laryngeal carcinoma. Impact on patient's survival.
    Pinilla M; González FM; López-Cortijo C; Arellano B; Herrero J; Trinidad A; Vergara J
    J Laryngol Otol; 2003 Jan; 117(1):63-6. PubMed ID: 12590859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolution of elective neck dissection in N0 laryngeal cancer.
    Gallo O; Deganello A; Scala J; De Campora E
    Acta Otorhinolaryngol Ital; 2006 Dec; 26(6):335-44. PubMed ID: 17633152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of contralateral N0 neck in pyriform sinus carcinoma.
    Koo BS; Lim YC; Lee JS; Kim YH; Kim SH; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1268-72. PubMed ID: 16826073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Relevant factors and management for patients with squamous carcinoma in tongue without clinical cervical lymphatic node metastasis].
    Lin GC; Qiu WL; Zhang ZY; Zhang CP; Zu HG; Sun J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):5-8. PubMed ID: 12760766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Internal jugular vein preservation in neck dissection for pN1-N2c oral and oropharyngeal carcinoma.
    Pontes E; Filho JG; Agra IM; Carvalho AL; Magrin J; Kowalski LP
    Am J Otolaryngol; 2007; 28(5):316-20. PubMed ID: 17826532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Routine inclusion of level IV in neck dissection for squamous cell carcinoma of the larynx: is it justified?
    Khafif A; Fliss DM; Gil Z; Medina JE
    Head Neck; 2004 Apr; 26(4):309-12. PubMed ID: 15054733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathological feature and management of occult lymphatic metastasis in supraglottic carcinoma].
    Jia SS; Wang YY; Pei R; Sun J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Feb; 40(2):103-5. PubMed ID: 16429726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early supraglottic cancer: how extensive must surgical resection be, if used alone?
    Dünne AA; Davis RK; Dalchow CV; Sesterhenn AM; Werner JA
    J Laryngol Otol; 2006 Sep; 120(9):764-9. PubMed ID: 16870034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Level choice of the neck dissection in clinical N0 patients with supraglottic cancer].
    Zhang N; Han D; Jia S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):83-5. PubMed ID: 12768712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cervical management in the N0 squamous cell carcinoma of the tongue].
    Wu Y; Tu G; Tang P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Jul; 34(4):199-201. PubMed ID: 11776903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of midline crossing of lateral supraglottic cancer on contralateral cervical lymph node metastasis.
    Yılmaz T; Süslü N; Atay G; Günaydın RÖ; Bajin MD; Özer S
    Acta Otolaryngol; 2015 May; 135(5):484-8. PubMed ID: 25677524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of histopathological parameters in 51 supraglottic squamous cell carcinomas.
    Barona de Guzmán R; Martorell MA; Basterra J; Armengot M; Alvarez-Valdés R; Garin L
    Laryngoscope; 1993 May; 103(5):538-40. PubMed ID: 8483372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinicopathological study on patterns of cervical lymph node metastases from squamous cell carcinomas (SCC) of the head and neck].
    Li X; Li L; Wei W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):206-9. PubMed ID: 9642343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
    Koo BS; Lim YC; Lee JS; Choi EC
    Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of metastases at the area of the supraretrospinal (level IIB) lymph node in laryngeal cancer.
    Sezen OS; Kubilay U; Haytoglu S; Unver S
    Head Neck; 2007 Dec; 29(12):1111-4. PubMed ID: 17636538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
    Yücetürk AV; Celik O; Eskiizmir G
    Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Conservative surgical treatment of supraglottic cancer and lymph node metastases].
    Pignataro O
    Arch Otorhinolaryngol Suppl; 1991; 1():23-9. PubMed ID: 1867568
    [No Abstract]   [Full Text] [Related]  

  • 58. [Postoperative radiotherapy in N0 laryngeal cancer].
    Maillard S; Jovenin N; Cauchois A; Froissart D; Merol JC; Chays A; Nguyen TD
    Cancer Radiother; 2005 Sep; 9(5):285-92. PubMed ID: 16168697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
    Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Supraglottic laryngectomy--series report and analysis of results.
    Adamopoulos G; Yotakis I; Apostolopoulos K; Manolopoulos L; Kandiloros D; Ferekidis E
    J Laryngol Otol; 1997 Aug; 111(8):730-4. PubMed ID: 9327010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.